-
Acumen Announces Pricing of Upsized $130 Million Public Offering
-
Acumen Pharmaceuticals (ABOS) Announces $100M Proposed Public Offering of Common Stock
-
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock

